Clovis Oncology says could file for bankruptcy in 'very near term'
09/11/2022 13:27
Nov 9 (Reuters) - Clovis Oncology CLVS.O said on Wednesday it was likely to file for bankruptcy "in the very near term" as the company struggles to sell its cancer drug Rubraca. (Reporting by Leroy Leo in Bengaluru; editing by Milla Nissi) ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber